, Clearmind Medicine Inc (NASDAQ:CMND)’s traded shares were 63.52 million, with the beta value of the company hitting -1.54. , the stock’s price was $1.76, reflecting an intraday gain of 31.37% or $0.42. The 52-week high for the CMND share is $16.19, that puts it down -819.89 from that peak though still a striking 47.73% gain since the share price plummeted to a 52-week low of $0.92. The company’s market capitalization is $5.58M, and the average trade volume was 1.28 million shares over the past three months.
Clearmind Medicine Inc (NASDAQ:CMND) trade information
Clearmind Medicine Inc (CMND) registered a 31.37% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 31.37% in intraday trading to $1.76, hitting a weekly high. The stock’s 5-day price performance is 21.40%, and it has moved by 55.78% in 30 days. Based on these gigs, the overall price performance for the year is -87.78%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -24.88%.
CMND Dividends
Clearmind Medicine Inc is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
